Scynexis SCYX
NASDAQ SCYX
$5.19 +0.04 (+0.78%)
As of: Aug 20, 2026 · 3:59 PM EDT

Scynexis (SCYX) Liabilities and Shareholders Equity (2013 - 2026)

Scynexis' (SCYX) quarterly Liabilities and Shareholders Equity came in at $77.6 million in Q1 2026, up 14.3% YoY from $67.9 million in Q1 2025, and up 31.51% on a QoQ basis from $59.0 million in Q4 2025.

Scynexis (SCYX) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has 14 years of Liabilities and Shareholders Equity data on file, last reported at $77.6 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 14.3% year-over-year to $77.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $248.4 million (down 32.02% YoY) and the FY2025 annual result came in at $59.0 million, down 34.88% from the prior year.
  • Liabilities and Shareholders Equity climbed to $77.6 million in Q1 2026, from $59.0 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $154.9 million in Q2 2023 to a low of $51.1 million in Q3 2025.
  • A 5-year average of $98.9 million and a median of $99.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity surged 68.22% — and 2025, when it slumped 48.43%.
  • Tracing SCYX's Liabilities and Shareholders Equity over 5 years: stood at $87.8 million in 2022, then soared by 46.24% to $128.4 million in 2023, then decreased by 29.41% to $90.6 million in 2024, then sank by 34.88% to $59.0 million in 2025, then jumped by 31.51% to $77.6 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $77.6 million (Q1 2026), $59.0 million (Q4 2025), and $51.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 6.18 Bn
10 Scynexis 61.37 Mn -53.33 Mn - 74.97 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 74.97 Mn
Mar 31, 2026 77.63 Mn
Dec 31, 2025 59.03 Mn
Sep 30, 2025 51.07 Mn
Jun 30, 2025 60.69 Mn
Mar 31, 2025 67.92 Mn
Dec 31, 2024 90.64 Mn
Sep 30, 2024 99.04 Mn
Jun 30, 2024 107.81 Mn
Mar 31, 2024 118.25 Mn
Dec 31, 2023 128.41 Mn
Sep 30, 2023 148.55 Mn
Jun 30, 2023 154.86 Mn
Mar 31, 2023 70.30 Mn
Dec 31, 2022 87.81 Mn
Sep 30, 2022 112.29 Mn
Jun 30, 2022 135.61 Mn
Mar 31, 2022 111.56 Mn
Dec 31, 2021 119.84 Mn
Sep 30, 2021 109.88 Mn